Bennett C Frank

Avg. Two Year Performance

No purchase track record
(19%) Avg. Sale Return
(9%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return1%(2%)(6%)(7%)(19%)
Sale Success Rate26 of 4119 of 4122 of 4114 of 4116 of 41
Drugs » Drug Manufacturers - Other

EVP, Chief Scientific Officer:

Holdings: 79.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--